Your browser doesn't support javascript.
loading
Design and validation of a multi-task, multi-context protocol for real-world gait simulation.
Scott, Kirsty; Bonci, Tecla; Salis, Francesca; Alcock, Lisa; Buckley, Ellen; Gazit, Eran; Hansen, Clint; Schwickert, Lars; Aminian, Kamiar; Bertuletti, Stefano; Caruso, Marco; Chiari, Lorenzo; Sharrack, Basil; Maetzler, Walter; Becker, Clemens; Hausdorff, Jeffrey M; Vogiatzis, Ioannis; Brown, Philip; Del Din, Silvia; Eskofier, Björn; Paraschiv-Ionescu, Anisoara; Keogh, Alison; Kirk, Cameron; Kluge, Felix; Micó-Amigo, Encarna M; Mueller, Arne; Neatrour, Isabel; Niessen, Martijn; Palmerini, Luca; Sillen, Henrik; Singleton, David; Ullrich, Martin; Vereijken, Beatrix; Froehlich, Marcel; Brittain, Gavin; Caulfield, Brian; Koch, Sarah; Carsin, Anne-Elie; Garcia-Aymerich, Judith; Kuederle, Arne; Yarnall, Alison; Rochester, Lynn; Cereatti, Andrea; Mazzà, Claudia.
Afiliação
  • Scott K; Department of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK. kscott3@sheffield.ac.uk.
  • Bonci T; Department of Mechanical Engineering, The University of Sheffield, Sheffield, UK. kscott3@sheffield.ac.uk.
  • Salis F; Department of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK.
  • Alcock L; Department of Mechanical Engineering, The University of Sheffield, Sheffield, UK.
  • Buckley E; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Gazit E; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Hansen C; Department of Mechanical Engineering and Insigneo Institute for in Silico Medicine, The University of Sheffield, Sheffield, UK.
  • Schwickert L; Department of Mechanical Engineering, The University of Sheffield, Sheffield, UK.
  • Aminian K; Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Bertuletti S; Department of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Caruso M; Robert Bosch Gesellschaft für Medizinische Forschung, Stuttgart, Germany.
  • Chiari L; Laboratory of Movement Analysis and Measurement, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Sharrack B; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Maetzler W; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Becker C; Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy.
  • Hausdorff JM; PolitoBIOMed Lab, Biomedical Engineering Lab, Politecnico di Torino, Turin, Italy.
  • Vogiatzis I; Department of Electrical, Electronic and Information Engineering «Guglielmo Marconi¼, University of Bologna, Bologna, Italy.
  • Brown P; Health Sciences and Technologies-Interdepartmental Center for Industrial Research (CIRI-SDV), University of Bologna, Bologna, Italy.
  • Del Din S; Department of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Eskofier B; Department of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Paraschiv-Ionescu A; Robert Bosch Gesellschaft für Medizinische Forschung, Stuttgart, Germany.
  • Keogh A; Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Kirk C; Department of Sport, Exercise and Rehabilitation, Northumbria University Newcastle, Newcastle upon Tyne, UK.
  • Kluge F; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Micó-Amigo EM; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Mueller A; Machine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Neatrour I; Laboratory of Movement Analysis and Measurement, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Niessen M; Insight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
  • Palmerini L; School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
  • Sillen H; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Singleton D; Machine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Ullrich M; Novartis Institutes of Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Vereijken B; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Froehlich M; Novartis Institutes of Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Brittain G; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Caulfield B; McRoberts BV, The Hague, The Netherlands.
  • Koch S; Department of Electrical, Electronic and Information Engineering «Guglielmo Marconi¼, University of Bologna, Bologna, Italy.
  • Carsin AE; Health Sciences and Technologies-Interdepartmental Center for Industrial Research (CIRI-SDV), University of Bologna, Bologna, Italy.
  • Garcia-Aymerich J; Digital Health R&D, AstraZeneca, Sweden.
  • Kuederle A; Insight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
  • Yarnall A; School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
  • Rochester L; Machine Learning and Data Analytics Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Cereatti A; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
  • Mazzà C; Grünenthal GmbH, Aachen, Germany.
J Neuroeng Rehabil ; 19(1): 141, 2022 12 16.
Article em En | MEDLINE | ID: mdl-36522646
ABSTRACT

BACKGROUND:

Measuring mobility in daily life entails dealing with confounding factors arising from multiple sources, including pathological characteristics, patient specific walking strategies, environment/context, and purpose of the task. The primary aim of this study is to propose and validate a protocol for simulating real-world gait accounting for all these factors within a single set of observations, while ensuring minimisation of participant burden and safety.

METHODS:

The protocol included eight motor tasks at varying speed, incline/steps, surface, path shape, cognitive demand, and included postures that may abruptly alter the participants' strategy of walking. It was deployed in a convenience sample of 108 participants recruited from six cohorts that included older healthy adults (HA) and participants with potentially altered mobility due to Parkinson's disease (PD), multiple sclerosis (MS), proximal femoral fracture (PFF), chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF). A novelty introduced in the protocol was the tiered approach to increase difficulty both within the same task (e.g., by allowing use of aids or armrests) and across tasks.

RESULTS:

The protocol proved to be safe and feasible (all participants could complete it and no adverse events were recorded) and the addition of the more complex tasks allowed a much greater spread in walking speeds to be achieved compared to standard straight walking trials. Furthermore, it allowed a representation of a variety of daily life relevant mobility aspects and can therefore be used for the validation of monitoring devices used in real life.

CONCLUSIONS:

The protocol allowed for measuring gait in a variety of pathological conditions suggests that it can also be used to detect changes in gait due to, for example, the onset or progression of a disease, or due to therapy. TRIAL REGISTRATION ISRCTN-12246987.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Marcha Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: J Neuroeng Rehabil Assunto da revista: ENGENHARIA BIOMEDICA / NEUROLOGIA / REABILITACAO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Marcha Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: J Neuroeng Rehabil Assunto da revista: ENGENHARIA BIOMEDICA / NEUROLOGIA / REABILITACAO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido